NCT05940766Recruiting
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
Summary
In children and adolescents undergoing chemotherapy for cancer, fever in neutropenia (FN) is the most frequent potentially lethal complication of chemotherapy for cancer. Emergency hospitalization and empirical treatment with i.v. broad-spectrum antibiotics have reduced lethality from \>50% in certain high risk situations to \<1%. Fever without neutropenia is a further complication requiring emergency evaluation and often emergency treatment. Continuous monitoring of fever leads to earlier fever detection compared to the usual discrete fever measurements performed only for clinical reasons. Earlier detection of fever leads to earlier assessment and treatment and thus can reduce the risk of complications. This study primarily aims to assess, in pediatric patients undergoing chemotherapy for cancer, the efficacy of automated fever alerts resulting from continuous fever monitoring (CFM) using a wearable device (WD), measured by the duration of intravenous antibiotics (i.v. AB) given for any cause.
Inclusion criteria
• Chemotherapy treatment because of any malignancy expected to last ≥2 months at time of recruitment for myelosuppressive therapy, or at least 1 cycle of myeloablative chemotherapy followed by hematopoietic stem cell transplantation • Age ≥1 month and \<18 years at time of recruitment • Written informed consent from patients and/or parents
Exclusion criteria
• Neonates \<1 months • Local skin disease prohibiting wearing of the WD • Denied written informed consent from patients and/or parents • Inclusion of vulnerable participants mandatory as vital signs and FN episodes differ significantly in children and adults
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- Insel Gruppe AG, University Hospital Bern(Other)
- Protocol no.
- Swiss 2024 Fever Monitoring
- Conditions
- Pediatric Oncology Patients With Risk for Infections
- Interventions
- Other
Treatments studied
- Automated fever alerts
Collaborators
ETH Zurich
Locations · 1
- Bern, SwitzerlandChildrens' Clinc Bern, Inselspital BernRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: October 22, 2026).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.